A synthetic version of parathyroid hormone (PTH) produced by the parathyroid glands.
Used for treating osteoporosis.
Uses:
Postmenopausal osteoporosis.
Glucocorticoid-induced osteoporosis.
Therapeutic Effects:
Stimulates the formation of new bone tissue.
Increases bone mineral density.
Enhances bone strength.
Reduces fracture risk.
Promotes bone healing.
Offers significant benefits such as increased bone density, fracture risk reduction, improved quality of life.
Interaction with Other Drugs:
Inform the doctor about all medicines, including prescription, over-the-counter, nutritional or vitamin supplements, and herbal products.
Certain medications may interact with Osteri 750mcg injection, reducing effectiveness or causing undesirable side effects.
Storage:
Store at controlled temperature, between 2–8°C.
Keep away from moisture, heat, and light.
Do not freeze.
Keep away from children and pets.
Administration:
Typically administered by a healthcare professional.
Usually given as an injection.
Dosage and duration of treatment determined by healthcare provider based on specific infection and individual factors.
Safety Advice:
Pregnancy: the safety of Osteri 750mcg injection use during pregnancy has not been established.
Breastfeeding: women should consult a doctor while breastfeeding while taking the Osteri 750mcg injection.
Lungs: consult with healthcare provider if you have a pre-existing lung condition.
Liver: consult with healthcare provider if you have a liver condition.
Alcohol: avoid consuming alcohol while taking Osteri 750mcg injection.
Driving: avoid driving or operating heavy machinery if experiencing side effects such as dizziness, drowsiness, or fatigue.
Side Effects:
Serious: hypercalcemia, allergic reactions, skin reactions at the injection site, osteosarcoma, orthostatic hypotension.
Common: arthralgia, nerve pain, nausea, sickness, headache, dizziness, increased sweating, breathlessness, muscle cramps, increase in blood cholesterol levels, chest pain, burning sensation below the breast bone, anemia.
FAQs:
Q1. Can Osteri 750mcg injection be used in individuals with a history of cancer?
Osteri 750mcg injection is generally not recommended for individuals with a history of cancer, especially skeletal malignancies or bone metastases.
Q2. Can Osteri 750mcg injection be used in men with osteoporosis?
Yes, Osteri 750mcg injection can be used in men with osteoporosis.
Q3. Can Osteri 750mcg injection be used in individuals with a history of kidney disease?
Osteri 750mcg injection can be used in individuals with mild to moderate kidney impairment. Caution is advised in individuals with severe kidney disease.
Q4. Can Osteri 750mcg injection be used in individuals with a history of fractures?
Osteri 750mcg injection is commonly prescribed for individuals with a history of fragility fractures.
Q5. Can Osteri 750mcg injection be used as a first-line treatment for osteoporosis?
Osteri 750mcg injection is typically not used as a first-line treatment for osteoporosis.
Q6. What are the potential long-term effects of Osteri 750mcg injection?
The long-term effects of Osteri 750mcg injection have yet to be well understood, particularly beyond the recommended treatment duration of 2 years.
Q7. What are the side effects of Osteri 750mcg injection?
Osteri 750mcg injection may cause side effects, including common ones such as injection site reactions, nausea, dizziness, and headache. Serious side effects, though rare, can include the development of osteosarcoma, a type of bone cancer, and the potential for hypercalcemia.